Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Related records

Trials (48)

• A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)
• A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)
• A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
• A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
• A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19
• A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried
• A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)
• BCG for Therapeutic Use Phase I Clinical Trial
• BCG for Therapeutic Use Phase Ⅲ Clinical Trial
• C-TST for Diagnosis of Latent Mycobacterium Tuberculosis Infection in Indonesia
• Clinical Study of BCG Vaccine for Intradermal Injection
• Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)
• Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III-healthy)
• Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen
• Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen for Children
• Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above
• Clinical Study of Recombinant Novel Coronavirus Vaccine
• Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine
• Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)
• Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)